Global Tumor-Infiltrating Lymphocyte Therapy Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Combined with IL-2
1.2.3 Not Combined with IL-2
1.3 Market by Application
1.3.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Melanoma
1.3.3 Cervical Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Perspective (2021–2032)
2.2 Global Tumor-Infiltrating Lymphocyte Therapy Growth Trends by Region
2.2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Region (2021–2026)
2.2.3 Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Region (2027–2032)
2.3 Tumor-Infiltrating Lymphocyte Therapy Market Dynamics
2.3.1 Tumor-Infiltrating Lymphocyte Therapy Industry Trends
2.3.2 Tumor-Infiltrating Lymphocyte Therapy Market Drivers
2.3.3 Tumor-Infiltrating Lymphocyte Therapy Market Challenges
2.3.4 Tumor-Infiltrating Lymphocyte Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Revenue
3.1.1 Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Revenue (2021–2026)
3.1.2 Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Tumor-Infiltrating Lymphocyte Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Tumor-Infiltrating Lymphocyte Therapy Revenue
3.4 Global Tumor-Infiltrating Lymphocyte Therapy Market Concentration Ratio
3.4.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor-Infiltrating Lymphocyte Therapy Revenue in 2025
3.5 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy Head Offices and Areas Served
3.6 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Products and Applications
3.7 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Tumor-Infiltrating Lymphocyte Therapy Breakdown Data by Type
4.1 Global Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Type (2021–2026)
4.2 Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Type (2027–2032)
5 Tumor-Infiltrating Lymphocyte Therapy Breakdown Data by Application
5.1 Global Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Application (2021–2026)
5.2 Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Tumor-Infiltrating Lymphocyte Therapy Market Size (2021–2032)
6.2 North America Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021–2026)
6.4 North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size (2021–2032)
7.2 Europe Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021–2026)
7.4 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size (2021–2032)
8.2 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size (2021–2032)
9.2 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021–2026)
9.4 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size (2021–2032)
10.2 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Iovance Biotherapeutics
11.1.1 Iovance Biotherapeutics Company Details
11.1.2 Iovance Biotherapeutics Business Overview
11.1.3 Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.1.4 Iovance Biotherapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.1.5 Iovance Biotherapeutics Recent Development
11.2 Moffitt Cancer Center
11.2.1 Moffitt Cancer Center Company Details
11.2.2 Moffitt Cancer Center Business Overview
11.2.3 Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Introduction
11.2.4 Moffitt Cancer Center Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.2.5 Moffitt Cancer Center Recent Development
11.3 Essen Biotech
11.3.1 Essen Biotech Company Details
11.3.2 Essen Biotech Business Overview
11.3.3 Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Introduction
11.3.4 Essen Biotech Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.3.5 Essen Biotech Recent Development
11.4 Turnstone Biologics
11.4.1 Turnstone Biologics Company Details
11.4.2 Turnstone Biologics Business Overview
11.4.3 Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.4.4 Turnstone Biologics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.4.5 Turnstone Biologics Recent Development
11.5 Obsidian Therapeutics
11.5.1 Obsidian Therapeutics Company Details
11.5.2 Obsidian Therapeutics Business Overview
11.5.3 Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.5.4 Obsidian Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.5.5 Obsidian Therapeutics Recent Development
11.6 Hervor Therapeutics
11.6.1 Hervor Therapeutics Company Details
11.6.2 Hervor Therapeutics Business Overview
11.6.3 Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.6.4 Hervor Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.6.5 Hervor Therapeutics Recent Development
11.7 Intima Bioscience
11.7.1 Intima Bioscience Company Details
11.7.2 Intima Bioscience Business Overview
11.7.3 Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Introduction
11.7.4 Intima Bioscience Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.7.5 Intima Bioscience Recent Development
11.8 Instil Bio
11.8.1 Instil Bio Company Details
11.8.2 Instil Bio Business Overview
11.8.3 Instil Bio Tumor-Infiltrating Lymphocyte Therapy Introduction
11.8.4 Instil Bio Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.8.5 Instil Bio Recent Development
11.9 Shanghai Juncell Therapeutics
11.9.1 Shanghai Juncell Therapeutics Company Details
11.9.2 Shanghai Juncell Therapeutics Business Overview
11.9.3 Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.9.4 Shanghai Juncell Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.9.5 Shanghai Juncell Therapeutics Recent Development
11.10 Suzhou BlueHorse Therapeutics
11.10.1 Suzhou BlueHorse Therapeutics Company Details
11.10.2 Suzhou BlueHorse Therapeutics Business Overview
11.10.3 Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.10.4 Suzhou BlueHorse Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.10.5 Suzhou BlueHorse Therapeutics Recent Development
11.11 Grit Biotechnology
11.11.1 Grit Biotechnology Company Details
11.11.2 Grit Biotechnology Business Overview
11.11.3 Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Introduction
11.11.4 Grit Biotechnology Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.11.5 Grit Biotechnology Recent Development
11.12 TCRCure Biopharma
11.12.1 TCRCure Biopharma Company Details
11.12.2 TCRCure Biopharma Business Overview
11.12.3 TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Introduction
11.12.4 TCRCure Biopharma Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.12.5 TCRCure Biopharma Recent Development
11.13 BioSyngen
11.13.1 BioSyngen Company Details
11.13.2 BioSyngen Business Overview
11.13.3 BioSyngen Tumor-Infiltrating Lymphocyte Therapy Introduction
11.13.4 BioSyngen Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.13.5 BioSyngen Recent Development
11.14 Sino-Cell Biomed
11.14.1 Sino-Cell Biomed Company Details
11.14.2 Sino-Cell Biomed Business Overview
11.14.3 Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Introduction
11.14.4 Sino-Cell Biomed Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
11.14.5 Sino-Cell Biomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Combined with IL-2
Table 3. Key Players of Not Combined with IL-2
Table 4. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2021–2026)
Table 8. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2027–2032)
Table 10. Tumor-Infiltrating Lymphocyte Therapy Market Trends
Table 11. Tumor-Infiltrating Lymphocyte Therapy Market Drivers
Table 12. Tumor-Infiltrating Lymphocyte Therapy Market Challenges
Table 13. Tumor-Infiltrating Lymphocyte Therapy Market Restraints
Table 14. Global Tumor-Infiltrating Lymphocyte Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Players (2021–2026)
Table 16. Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Tumor-Infiltrating Lymphocyte Therapy Revenue, 2025
Table 17. Ranking of Global Top Tumor-Infiltrating Lymphocyte Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Tumor-Infiltrating Lymphocyte Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Headquarters and Area Served
Table 20. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Products and Applications
Table 21. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Iovance Biotherapeutics Company Details
Table 47. Iovance Biotherapeutics Business Overview
Table 48. Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 49. Iovance Biotherapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 50. Iovance Biotherapeutics Recent Development
Table 51. Moffitt Cancer Center Company Details
Table 52. Moffitt Cancer Center Business Overview
Table 53. Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Product
Table 54. Moffitt Cancer Center Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 55. Moffitt Cancer Center Recent Development
Table 56. Essen Biotech Company Details
Table 57. Essen Biotech Business Overview
Table 58. Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Product
Table 59. Essen Biotech Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 60. Essen Biotech Recent Development
Table 61. Turnstone Biologics Company Details
Table 62. Turnstone Biologics Business Overview
Table 63. Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Product
Table 64. Turnstone Biologics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 65. Turnstone Biologics Recent Development
Table 66. Obsidian Therapeutics Company Details
Table 67. Obsidian Therapeutics Business Overview
Table 68. Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 69. Obsidian Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 70. Obsidian Therapeutics Recent Development
Table 71. Hervor Therapeutics Company Details
Table 72. Hervor Therapeutics Business Overview
Table 73. Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 74. Hervor Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 75. Hervor Therapeutics Recent Development
Table 76. Intima Bioscience Company Details
Table 77. Intima Bioscience Business Overview
Table 78. Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Product
Table 79. Intima Bioscience Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 80. Intima Bioscience Recent Development
Table 81. Instil Bio Company Details
Table 82. Instil Bio Business Overview
Table 83. Instil Bio Tumor-Infiltrating Lymphocyte Therapy Product
Table 84. Instil Bio Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 85. Instil Bio Recent Development
Table 86. Shanghai Juncell Therapeutics Company Details
Table 87. Shanghai Juncell Therapeutics Business Overview
Table 88. Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 89. Shanghai Juncell Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 90. Shanghai Juncell Therapeutics Recent Development
Table 91. Suzhou BlueHorse Therapeutics Company Details
Table 92. Suzhou BlueHorse Therapeutics Business Overview
Table 93. Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 94. Suzhou BlueHorse Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 95. Suzhou BlueHorse Therapeutics Recent Development
Table 96. Grit Biotechnology Company Details
Table 97. Grit Biotechnology Business Overview
Table 98. Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Product
Table 99. Grit Biotechnology Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 100. Grit Biotechnology Recent Development
Table 101. TCRCure Biopharma Company Details
Table 102. TCRCure Biopharma Business Overview
Table 103. TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Product
Table 104. TCRCure Biopharma Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 105. TCRCure Biopharma Recent Development
Table 106. BioSyngen Company Details
Table 107. BioSyngen Business Overview
Table 108. BioSyngen Tumor-Infiltrating Lymphocyte Therapy Product
Table 109. BioSyngen Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 110. BioSyngen Recent Development
Table 111. Sino-Cell Biomed Company Details
Table 112. Sino-Cell Biomed Business Overview
Table 113. Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Product
Table 114. Sino-Cell Biomed Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (US$ Million), 2021–2026
Table 115. Sino-Cell Biomed Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report


List of Figures
Figure 1. Tumor-Infiltrating Lymphocyte Therapy Picture
Figure 2. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Type: 2025 vs 2032
Figure 4. Combined with IL-2 Features
Figure 5. Not Combined with IL-2 Features
Figure 6. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Application: 2025 vs 2032
Figure 8. Melanoma Case Studies
Figure 9. Cervical Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Tumor-Infiltrating Lymphocyte Therapy Report Years Considered
Figure 12. Global Tumor-Infiltrating Lymphocyte Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Tumor-Infiltrating Lymphocyte Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region: 2025 vs 2032
Figure 15. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Players in 2025
Figure 16. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Tumor-Infiltrating Lymphocyte Therapy Revenue in 2025
Figure 18. North America Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2021–2032)
Figure 20. United States Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2021–2032)
Figure 24. Germany Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2021–2032)
Figure 32. China Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2021–2032)
Figure 40. Mexico Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2021–2032)
Figure 44. Israel Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Iovance Biotherapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 48. Moffitt Cancer Center Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 49. Essen Biotech Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 50. Turnstone Biologics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 51. Obsidian Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 52. Hervor Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 53. Intima Bioscience Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 54. Instil Bio Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 55. Shanghai Juncell Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 56. Suzhou BlueHorse Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 57. Grit Biotechnology Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 58. TCRCure Biopharma Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 59. BioSyngen Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 60. Sino-Cell Biomed Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit